1. A revisit of drugs and potential therapeutic targets against non-alcoholic fatty liver disease: learning from clinical trials

   • S. Zhu
   • Z. Wu
   • H. Zhou

   Review 15 October 2023 Pages: 761 - 776

   

2. Tall stature and gigantism in transition age: clinical and genetic aspects—a literature review and recommendations

   • V. Sada
   • G. Puliani
   • the TALENT group

   Review Open access 27 October 2023 Pages: 777 - 793

   

3. Refracture following vertebral fragility fracture when bone fragility is not recognized: summarizing findings from comparator arms of randomized clinical trials

   • G. Porcu
   • A. Biffi
   • G. Corrao

   Review Open access 03 November 2023 Pages: 795 - 818

   

4. Effect of SIRT1 gene single-nucleotide polymorphisms on susceptibility to type 1 diabetes in a Han Chinese population

   • J. Li
   • Y. Yang
   • Z. Zhou

   Original Article Open access 11 September 2023 Pages: 819 - 826

   

5. Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis

   • L. Croce
   • R. M. Ruggeri
   • M. Rotondi

   Original Article Open access 13 September 2023 Pages: 827 - 832

   

6. Targeted long-read sequencing for comprehensive detection of CYP21A2 mutations in patients with 21-hydroxylase deficiency

   • X. Zhang
   • Y. Gao
   • M. Nie

   Original Article 10 October 2023 Pages: 833 - 841

   

7. Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma

   • W. Qi
   • L. Cui
   • W. Xia

   Original Article 24 October 2023 Pages: 843 - 856

   

8. Evaluation of a large set of patients with Autoimmune Polyglandular Syndrome from a single reference centre in context of different classifications

   • E. Gatta
   • V. Maltese
   • C. Cappelli

   Original Article Open access 26 September 2023 Pages: 857 - 864

   

9. The triglycerides and glucose index is more strongly associated with metabolically healthy obesity phenotype than the lipid and obesity indices

   • Y. Weyman-Vela
   • F. Guerrero-Romero
   • L. E. Simental-Mendía

   Original Article 28 September 2023 Pages: 865 - 871

   

10. Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets

    • G. I. Baroncelli
    • M. R. Sessa
    • P. Comberiati

    Original Article Open access 22 November 2023 Pages: 873 - 882

    

11. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes

    • J. He
    • M. Yang
    • K. Dou

    Original Article 30 September 2023 Pages: 883 - 894

    

12. Ticagrelor was associated with lower fracture risk than clopidogrel in the dual anti-platelet regimen among patients with acute coronary syndrome treated with percutaneous coronary intervention

    • D. T. W. Lui
    • C. H. Wong
    • A. K. Y. Ng

    Original Article Open access 30 September 2023 Pages: 895 - 902

    

13. Body weight variation is not an independent factor in the determination of functional hypothalamic amenorrhea in anorexia nervosa

    • C. Cacciatore
    • B. Cangiano
    • L. Persani

    Original Article Open access 09 October 2023 Pages: 903 - 911

    

14. Blood lipid profile, HbA1c, fasting glucose, and diabetes: a cohort study and a two-sample Mendelian randomization analysis

    • Y.-C. Lin
    • H.-P. Tu
    • T.-N. Wang

    Original Article 25 October 2023 Pages: 913 - 925

    

15. Body mass index is a good predictor of metabolic abnormalities in polycystic ovary syndrome

    • F. Fruzzetti
    • T. Fidecicchi
    • M. Tonacchera

    Original Article 31 October 2023 Pages: 927 - 936

    

16. Role of active and environmental tobacco smoke on susceptibility to osteoporosis in women undergoing dual-X-ray absorptiometry

    • A. Vergatti
    • V. Abate
    • D. Rendina

    Original Article Open access 11 October 2023 Pages: 937 - 946

    

17. Hypocalcemia in combination with hyperphosphatemia impairs muscle cell differentiation in vitro

    • V. M. Bimonte
    • G. Catanzaro
    • S. Migliaccio

    Original Article Open access 11 October 2023 Pages: 947 - 957

    

18. Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study

    • R. M. Ruggeri
    • B. Altieri
    • NIKE Group

    Original Article Open access 14 October 2023 Pages: 959 - 971

    

19. Sudomotor dysfunction is associated with impaired left ventricular diastolic function in persons with type 2 diabetes: a cross-sectional study

    • X. Chen
    • X. Shui
    • X. Yang

    Original Article 24 November 2023 Pages: 973 - 982

    

20. Adiponectin rs1501299 and chemerin rs17173608 gene polymorphism in children with type 1 diabetes mellitus: relation with macroangiopathy and peripheral artery disease

    • N. Y. Salah
    • S. S. Madkour
    • R. A. E. H. Mahmoud

    Original Article Open access 13 October 2023 Pages: 983 - 994

    

21. Establishing a valid cohort of patients with acromegaly by combining the National Patient Register with the Swedish Pituitary Register

    • J. Robèrt
    • E. Tsatsaris
    • B. Edén Engström

    Original Article Open access 18 October 2023 Pages: 995 - 1003

    

22. Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains

    • D. Norello
    • G. Rastrelli
    • A. Peri

    Original Article Open access 26 October 2023 Pages: 1005 - 1014

    

23. HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4

    • J. Yu
    • J. Da
    • Y. Zha

    Original Article 27 February 2024 Pages: 1015 - 1027

    

24. Gut microbiota, a potential cause of higher insulin sensitivity in children with Prader–Willi syndrome

    • M.-L. Zhong
    • Y.-Q. Cai
    • C.-C. Zou

    Brief Report 20 September 2023 Pages: 1029 - 1036

    

25. Adolescent polycystic ovary syndrome without obesity: HOTAIR rs1443512 genotype relates to fat mass and to the redistribution of fat mass on low-dose pioglitazone

    • F. de Zegher
    • M. Díaz
    • L. Ibáñez

    Rapid Communication 08 October 2023 Pages: 1037 - 1043

    

26. Nano Morgante: the most famous buffoon of Cosimo I de’Medici

    • H. Valdes-Socin

    Endo&Art 24 July 2023 Pages: 1045 - 1046